ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26%

$5.60

Market Cap $86.68M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Pause in Trading	PRICE SENSITIVE	21/05/21	116.45KB	Share
AVR	Appendix 2A		30/04/21	303.47KB	Share
AVR	ComASUR Key Milestone	PRICE SENSITIVE	27/04/21	191.15KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/21	319.41KB	Share
AVR	Appendix 4G and Corporate Governance Statement		15/04/21	1.69MB	Share
AVR	Annual Report to shareholders		15/04/21	5.18MB	Share
AVR	Change in substantial holding		15/04/21	203.56KB	Share
AVR	Update to Notice of Annual General Meeting		14/04/21	135.7KB	Share
AVR	Cleansing Notice (Notes)		14/04/21	285.21KB	Share
AVR	Cleansing Notice (shares)		14/04/21	194.51KB	Share
AVR	Appendix 2A		14/04/21	304.97KB	Share
AVR	Proposed issue of Securities - AVR		12/04/21	30.18KB	Share
AVR	Expanded Funding Package	PRICE SENSITIVE	12/04/21	225.58KB	Share
AVR	Appendix 2A		08/04/21	303.17KB	Share
AVR	Appendix 2A		29/03/21	303.49KB	Share
AVR	Anti-Calcification Study	PRICE SENSITIVE	29/03/21	204.67KB	Share
AVR	Results of Meeting		19/03/21	206.37KB	Share
AVR	Notice of Annual General Meeting and Director Nominations		15/03/21	135.09KB	Share
AVR	Response to ASX Price and Volume Query	PRICE SENSITIVE	09/03/21	306.69KB	Share
AVR	Appendix 3G		02/03/21	275.09KB	Share
AVR	Change in substantial holding		25/02/21	248.79KB	Share
AVR	Preliminary Financial Report	PRICE SENSITIVE	18/02/21	228.83KB	Share
AVR	Full Year Statutory Accounts	PRICE SENSITIVE	18/02/21	1.73MB	Share
AVR	Notice of Extraordinary General Meeting/Proxy Form		17/02/21	2.04MB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	22/01/21	295.12KB	Share
AVR	Becoming a substantial holder		22/01/21	201.31KB	Share
AVR	Cleansing Notice (Convertible Notes)		20/01/21	336.67KB	Share
AVR	Cleansing Notice (Shares)		20/01/21	195.43KB	Share
AVR	Appendix 2A		20/01/21	301.43KB	Share
AVR	First Tranche Closing - Mercer	PRICE SENSITIVE	20/01/21	179.92KB	Share
AVR	Cleansing Statement		06/01/21	193.67KB	Share
AVR	Reinstatement to Official Quotation	PRICE SENSITIVE	06/01/21	86.22KB	Share
AVR	Proposed issue of Securities - AVR		06/01/21	35.99KB	Share
AVR	Funding Package	PRICE SENSITIVE	06/01/21	294.48KB	Share
AVR	Research and Development Advance	PRICE SENSITIVE	04/01/21	158.9KB	Share
AVR	Appendix 2A		30/12/20	307.29KB	Share
AVR	Placement	PRICE SENSITIVE	30/12/20	215.3KB	Share
AVR	Suspension from Official Quotation	PRICE SENSITIVE	29/12/20	240.75KB	Share
AVR	Trading Halt	PRICE SENSITIVE	23/12/20	587.85KB	Share
AVR	Final Director's Interest Notice		17/12/20	236.75KB	Share
AVR	Non-Executive Director Resignation		16/12/20	159.33KB	Share
AVR	Change of Director's Interest Notice		15/12/20	219.82KB	Share
AVR	Cancelled Options		15/12/20	163.74KB	Share
AVR	AVR presenting Switzer Small & Micro-Cap Conference		27/11/20	128.01KB	Share
AVR	DurAVR SELECTED AS A BEST INNOVATION - PCR LONDON VALVES	PRICE SENSITIVE	23/11/20	153.04KB	Share
AVR	Anteris to Present at Credit Suisse Structural Heart Forum		19/11/20	184.4KB	Share
AVR	Anti-calcification Comparison Study Interim Results	PRICE SENSITIVE	10/11/20	160.09KB	Share
AVR	Appendix 3G		06/11/20	276.06KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	16/10/20	272.3KB	Share
AVR	Extension of Loan Facility		15/10/20	157.84KB	Share
AVR	DurAVR valve patient outcomes exceed expectations		09/10/20	186.53KB	Share
AVR	Cancelled Options		24/09/20	226.96KB	Share
AVR	Change in substantial holding		21/09/20	184.52KB	Share
AVR	Anteris Granted US Patent	PRICE SENSITIVE	08/09/20	177.64KB	Share
AVR	TAVR Medical Advisory Board Appointment		31/08/20	112.62KB	Share
AVR	Operations update		28/08/20	185.25KB	Share
AVR	Appendix 4D and Half Yearly Financial Report	PRICE SENSITIVE	20/08/20	1.39MB	Share
AVR	Unusual Trading Patterns	PRICE SENSITIVE	30/07/20	114.22KB	Share
AVR	TAVR Key Opinion Leader Symposium		28/07/20	646.8KB	Share
AVR	Response to Market Speculation	PRICE SENSITIVE	24/07/20	595.16KB	Share
AVR	Expired Options		24/07/20	614.32KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	22/07/20	777.31KB	Share
AVR	Ceasing to be a substantial holder		21/07/20	138.99KB	Share
AVR	Presentation - Symposium on Next Generation Technologies	PRICE SENSITIVE	21/07/20	2.54MB	Share
AVR	Becoming a substantial holder		20/07/20	105.98KB	Share
AVR	Change in substantial holding		16/07/20	3.73MB	Share
AVR	AVR host TAVR KOL Symposium moderated by Credit Suisse		10/07/20	218.28KB	Share
AVR	ANR host TAVR KOL Symposium moderated by Credit Suisse		09/07/20	112.81KB	Share
AVR	Cancelled Options		06/07/20	605.85KB	Share
AVR	Anteris Operations Update		02/07/20	91.63KB	Share
AVR	Appendix 3G		25/06/20	273.67KB	Share
AVR	Update to Change in substantial holding notice		23/06/20	84.7KB	Share
AVR	Change in substantial holding		22/06/20	198.17KB	Share
AVR	R&D Tax refund		18/06/20	77.51KB	Share
AVR	Early TAVR Animal Study commenced		17/06/20	80.05KB	Share
AVR	Change of company name and ASX code		22/05/20	98.75KB	Share
AVR	Anti-calcification Comparison Study		19/05/20	101.61KB	Share
AVR	Results of Meeting		15/05/20	246.79KB	Share
AVR	AGM CEO Presentation		15/05/20	8.89MB	Share
AVR	Second Patient successfully implanted in SAVR Trial		11/05/20	78.66KB	Share
AVR	Alteration to Notice of Meeting		07/05/20	1.26MB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/20	271.76KB	Share
AVR	Notice of Annual General Meeting/Proxy Form		09/04/20	812.91KB	Share
AVR	Appendix 4G		09/04/20	319.25KB	Share
AVR	Annual Report to shareholders		09/04/20	5.08MB	Share
AVR	SAVR trial patient discharged from hospital		06/04/20	74.03KB	Share
AVR	US FDA clearance for ADAPT tissue		06/04/20	117.61KB	Share
AVR	First in human trial commences	PRICE SENSITIVE	27/03/20	100.3KB	Share
AVR	Change of Director's Interest Notice		24/03/20	633.77KB	Share
AVR	Proposed issue of Securities - AHZ		23/03/20	25.2KB	Share
AVR	Coronavirus Mitigation Strategy		20/03/20	118.99KB	Share
AVR	Notice of Annual General Meeting and Director Nominations		19/03/20	195.57KB	Share
AVR	Approval for first-in-human study		11/03/20	117.9KB	Share
AVR	Preliminary Financial Report	PRICE SENSITIVE	28/02/20	237.04KB	Share
AVR	Appendix 4E and Full Year Accounts	PRICE SENSITIVE	28/02/20	1.42MB	Share
AVR	Results of Meeting		26/02/20	195.64KB	Share
AVR	Consolidation/Split - AHZ		25/02/20	28.67KB	Share
AVR	Finalisation of License with 4C Medical	PRICE SENSITIVE	03/02/20	153.58KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/20	230.25KB	Share
AVR	Notice of Extraordinary General Meeting/Proxy Form		24/01/20	2.22MB	Share

AVR Pause in Trading
21/05/21	PRICE SENSITIVE	116.45KB	Share
AVR Appendix 2A
30/04/21		303.47KB	Share
AVR ComASUR Key Milestone
27/04/21	PRICE SENSITIVE	191.15KB	Share
AVR Appendix 4C - quarterly
22/04/21	PRICE SENSITIVE	319.41KB	Share
AVR Appendix 4G and Corporate Governance Statement
15/04/21		1.69MB	Share
AVR Annual Report to shareholders
15/04/21		5.18MB	Share
AVR Change in substantial holding
15/04/21		203.56KB	Share
AVR Update to Notice of Annual General Meeting
14/04/21		135.7KB	Share
AVR Cleansing Notice (Notes)
14/04/21		285.21KB	Share
AVR Cleansing Notice (shares)
14/04/21		194.51KB	Share
AVR Appendix 2A
14/04/21		304.97KB	Share
AVR Proposed issue of Securities - AVR
12/04/21		30.18KB	Share
AVR Expanded Funding Package
12/04/21	PRICE SENSITIVE	225.58KB	Share
AVR Appendix 2A
08/04/21		303.17KB	Share
AVR Appendix 2A
29/03/21		303.49KB	Share
AVR Anti-Calcification Study
29/03/21	PRICE SENSITIVE	204.67KB	Share
AVR Results of Meeting
19/03/21		206.37KB	Share
AVR Notice of Annual General Meeting and Director Nominations
15/03/21		135.09KB	Share
AVR Response to ASX Price and Volume Query
09/03/21	PRICE SENSITIVE	306.69KB	Share
AVR Appendix 3G
02/03/21		275.09KB	Share
AVR Change in substantial holding
25/02/21		248.79KB	Share
AVR Preliminary Financial Report
18/02/21	PRICE SENSITIVE	228.83KB	Share
AVR Full Year Statutory Accounts
18/02/21	PRICE SENSITIVE	1.73MB	Share
AVR Notice of Extraordinary General Meeting/Proxy Form
17/02/21		2.04MB	Share
AVR Appendix 4C - quarterly
22/01/21	PRICE SENSITIVE	295.12KB	Share
AVR Becoming a substantial holder
22/01/21		201.31KB	Share
AVR Cleansing Notice (Convertible Notes)
20/01/21		336.67KB	Share
AVR Cleansing Notice (Shares)
20/01/21		195.43KB	Share
AVR Appendix 2A
20/01/21		301.43KB	Share
AVR First Tranche Closing - Mercer
20/01/21	PRICE SENSITIVE	179.92KB	Share
AVR Cleansing Statement
06/01/21		193.67KB	Share
AVR Reinstatement to Official Quotation
06/01/21	PRICE SENSITIVE	86.22KB	Share
AVR Proposed issue of Securities - AVR
06/01/21		35.99KB	Share
AVR Funding Package
06/01/21	PRICE SENSITIVE	294.48KB	Share
AVR Research and Development Advance
04/01/21	PRICE SENSITIVE	158.9KB	Share
AVR Appendix 2A
30/12/20		307.29KB	Share
AVR Placement
30/12/20	PRICE SENSITIVE	215.3KB	Share
AVR Suspension from Official Quotation
29/12/20	PRICE SENSITIVE	240.75KB	Share
AVR Trading Halt
23/12/20	PRICE SENSITIVE	587.85KB	Share
AVR Final Director's Interest Notice
17/12/20		236.75KB	Share
AVR Non-Executive Director Resignation
16/12/20		159.33KB	Share
AVR Change of Director's Interest Notice
15/12/20		219.82KB	Share
AVR Cancelled Options
15/12/20		163.74KB	Share
AVR AVR presenting Switzer Small & Micro-Cap Conference
27/11/20		128.01KB	Share
AVR DurAVR SELECTED AS A BEST INNOVATION - PCR LONDON VALVES
23/11/20	PRICE SENSITIVE	153.04KB	Share
AVR Anteris to Present at Credit Suisse Structural Heart Forum
19/11/20		184.4KB	Share
AVR Anti-calcification Comparison Study Interim Results
10/11/20	PRICE SENSITIVE	160.09KB	Share
AVR Appendix 3G
06/11/20		276.06KB	Share
AVR Appendix 4C - quarterly
16/10/20	PRICE SENSITIVE	272.3KB	Share
AVR Extension of Loan Facility
15/10/20		157.84KB	Share
AVR DurAVR valve patient outcomes exceed expectations
09/10/20		186.53KB	Share
AVR Cancelled Options
24/09/20		226.96KB	Share
AVR Change in substantial holding
21/09/20		184.52KB	Share
AVR Anteris Granted US Patent
08/09/20	PRICE SENSITIVE	177.64KB	Share
AVR TAVR Medical Advisory Board Appointment
31/08/20		112.62KB	Share
AVR Operations update
28/08/20		185.25KB	Share
AVR Appendix 4D and Half Yearly Financial Report
20/08/20	PRICE SENSITIVE	1.39MB	Share
AVR Unusual Trading Patterns
30/07/20	PRICE SENSITIVE	114.22KB	Share
AVR TAVR Key Opinion Leader Symposium
28/07/20		646.8KB	Share
AVR Response to Market Speculation
24/07/20	PRICE SENSITIVE	595.16KB	Share
AVR Expired Options
24/07/20		614.32KB	Share
AVR Appendix 4C - quarterly
22/07/20	PRICE SENSITIVE	777.31KB	Share
AVR Ceasing to be a substantial holder
21/07/20		138.99KB	Share
AVR Presentation - Symposium on Next Generation Technologies
21/07/20	PRICE SENSITIVE	2.54MB	Share
AVR Becoming a substantial holder
20/07/20		105.98KB	Share
AVR Change in substantial holding
16/07/20		3.73MB	Share
AVR AVR host TAVR KOL Symposium moderated by Credit Suisse
10/07/20		218.28KB	Share
AVR ANR host TAVR KOL Symposium moderated by Credit Suisse
09/07/20		112.81KB	Share
AVR Cancelled Options
06/07/20		605.85KB	Share
AVR Anteris Operations Update
02/07/20		91.63KB	Share
AVR Appendix 3G
25/06/20		273.67KB	Share
AVR Update to Change in substantial holding notice
23/06/20		84.7KB	Share
AVR Change in substantial holding
22/06/20		198.17KB	Share
AVR R&D Tax refund
18/06/20		77.51KB	Share
AVR Early TAVR Animal Study commenced
17/06/20		80.05KB	Share
AVR Change of company name and ASX code
22/05/20		98.75KB	Share
AVR Anti-calcification Comparison Study
19/05/20		101.61KB	Share
AVR Results of Meeting
15/05/20		246.79KB	Share
AVR AGM CEO Presentation
15/05/20		8.89MB	Share
AVR Second Patient successfully implanted in SAVR Trial
11/05/20		78.66KB	Share
AVR Alteration to Notice of Meeting
07/05/20		1.26MB	Share
AVR Appendix 4C - quarterly
22/04/20	PRICE SENSITIVE	271.76KB	Share
AVR Notice of Annual General Meeting/Proxy Form
09/04/20		812.91KB	Share
AVR Appendix 4G
09/04/20		319.25KB	Share
AVR Annual Report to shareholders
09/04/20		5.08MB	Share
AVR SAVR trial patient discharged from hospital
06/04/20		74.03KB	Share
AVR US FDA clearance for ADAPT tissue
06/04/20		117.61KB	Share
AVR First in human trial commences
27/03/20	PRICE SENSITIVE	100.3KB	Share
AVR Change of Director's Interest Notice
24/03/20		633.77KB	Share
AVR Proposed issue of Securities - AHZ
23/03/20		25.2KB	Share
AVR Coronavirus Mitigation Strategy
20/03/20		118.99KB	Share
AVR Notice of Annual General Meeting and Director Nominations
19/03/20		195.57KB	Share
AVR Approval for first-in-human study
11/03/20		117.9KB	Share
AVR Preliminary Financial Report
28/02/20	PRICE SENSITIVE	237.04KB	Share
AVR Appendix 4E and Full Year Accounts
28/02/20	PRICE SENSITIVE	1.42MB	Share
AVR Results of Meeting
26/02/20		195.64KB	Share
AVR Consolidation/Split - AHZ
25/02/20		28.67KB	Share
AVR Finalisation of License with 4C Medical
03/02/20	PRICE SENSITIVE	153.58KB	Share
AVR Appendix 4C - quarterly
31/01/20	PRICE SENSITIVE	230.25KB	Share
AVR Notice of Extraordinary General Meeting/Proxy Form
24/01/20		2.22MB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.60		Change 0.330(6.26%)		Mkt cap ! $86.68M

Open	High	Low	Value	Volume
$5.50	$5.60	$5.30	$89.45K	16.14K

Buyers (Bids)

No.	Vol.	Price($)
1	103	$5.30

Sellers (Offers)

Price($)	Vol.	No.
$5.98	992	1

View Market Depth

No.	Vol.	Price($)
1	103	5.300
1	920	5.270
1	613	5.240
1	576	5.200
1	20000	5.150

Price($)	Vol.	No.
5.980	992	1
5.990	3500	1
6.000	3719	2
6.050	20000	1
6.500	230	2

Last trade - 15.29pm 22/08/2025 (20 minute delay)


Last $5.59		Change 0.330 ( 4.68 %)
Open	High	Low	Volume
$5.59	$5.59	$5.29	3526
Last updated 15.28pm 22/08/2025 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Corporate Spotlight
Not Yet Available